Topadur Pharma

Zurich-Schlieren, Switzerland, 7 September 2023

We are thrilled to announce that TOPADUR Pharma AG has once again been recognized as one of Switzerland's top 25 scale-up companies.

This achievement is a demonstration to our team's dedication and our partners' support.

We are grateful for this recognition and remain committed to pushing the boundaries of innovation in the years to come.

Please check out the link below.

‍

1.7.21

Press Release

TOPADUR submits an Orphan Drug Designation application for TOP-N53

TOPADUR announces the submission of an application to the European Medicines Agency to receive Orphan Drug Designation Status.

6.6.24

Press Release

Topadur Pharma AG and Oshen Holdings SA Partner to Develop a Treatment for Alopecia

19.5.22

Press Release

Diabetic Retinopathy is a severe complication of diabetes and a cause of blindness in adults.